Dysfunctional white blood cells linked to heightened melanoma risk

Share on facebook
Share on twitter
Share on linkedin
Share on email
Share on print

Mayo Clinic study has found that 8 million to 10 million Americans over age 40 have an overabundance of cloned white blood cells, or lymphocytes, that hamper their immune systems. Although many who have this condition—called monoclonal B-cell lymphocytosis—do not experience any symptoms, a recent study shows they may have an elevated risk for several health complications, including melanoma. 

To access this subscriber-only content please log in or subscribe.

If your institution has a site license, log in with IP-login or register for a sponsored account.*
*Not all site licenses are enrolled in sponsored accounts.

Login Subscribe
Table of Contents

YOU MAY BE INTERESTED IN

Clinicians typically classify meningiomas—the most common type of brain tumor—into three grades, ranging from slow-growing to aggressive. But a new multi-institutional study suggests that appearances may be deceiving. If a tumor shows activity in a gene called telomerase reverse transcriptase, it tends to recur more quickly, even if it looks low-grade under the microscope.

Never miss an issue!

Get alerts for our award-winning coverage in your inbox.

Login